Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The sigma‑2 receptor/TMEM97 is an integral membrane protein involved broadly in cellular homeostasis—including lipid metabolism/cholesterol trafficking—and plays key roles both physiologically and pathologically across cancer biology and neurodegeneration research fields. It is a four-pass transmembrane protein primarily located in the endoplasmic reticulum. The receptor is highly expressed in several tissues, including the brain (notably cerebellum, motor cortex, hippocampus, substantia nigra), liver, kidney, and lungs. S2R forms a trimeric complex with Progesterone receptor membrane component 1 (PGRMC1) and Low-density lipoprotein receptor (LDLR). Ligands include small-molecule agonists and antagonists.
Sigma-2 receptor agonists show anticancer activity. Sigma-2 receptor antagonists provide neuroprotection/inhibit amyloid-beta oligomer toxicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sigma Receptor 2 (S2R).